Literature DB >> 16788687

Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors.

A M de Mattos1, J Prather, A J Olyaei, Y Shibagaki, D S Keith, M Mori, D J Norman, T Becker.   

Abstract

Cardiovascular mortality is increased in transplant recipients. However, studies including non-fatal events are critical to assess the burden of disease and to identify novel risk factors. We described the incidence of fatal and non-fatal events, and explored associations and interactions among traditional and transplant-specific risk factors and cardiovascular events (CVE) in a cohort of 922 patients transplanted between 1993 and 1998. One hundred and seventy-six patients experienced 201 CVE (111 cardiac, 48 cerebrovascular, 42 peripheral-vascular). Most CVE were non-fatal. Factors associated with cardiac events were (adjusted hazard ratios) tobacco (3.53; P<0.001), obesity (2.92; P<0.001), diabetes (2.63; P<0.001), multiple rejections (2.19; P=0.008), prior CVE (2.0; P=0.004), dialysis >1 year (1.91; P=0.007), and overweight status (1.68; P=0.04); with cerebrovascular events: diabetes and peritoneal dialysis (11.95; P<0.001), age >45 (6.77; P<0.001), diabetes (4.87; P<0.001), prior CVE (3.73; P<0.001), creatinine >141 micromol/l (3.16; P=0.001), peritoneal dialysis (3.06; P=0.027), and obesity (0.32; P=0.046); with peripheral-vascular events: diabetes (8.48; P<0.001), tobacco and cytomegalovirus (3.88; P<0.001), age >45 (2.31; P=0.019), and prior CVE (2.25; P=0.016); with mortality: tobacco and deceased-donor (3.52; P<0.001), age >45 (1.81; P=0.002), diabetes (1.76; P=0.002), pulse pressure (1.64; P=0.029), prior CVE (1.52; P=0.04), and dialysis >1 year (1.47; P=0.04). The majority of CVE post-transplant were non-fatal. Previous CVE was strongly associated with CVE post-transplant. Interactions among transplant-specific and traditional risks impacted significantly the incidence of CVE. Modifiable factors such as duration of dialysis, deceased-donor transplantation, and acute rejection should be viewed as cardiovascular risks.

Entities:  

Mesh:

Year:  2006        PMID: 16788687     DOI: 10.1038/sj.ki.5001628

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

1.  Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review.

Authors:  Krista L Lentine; Lisa A Rocca-Rey; Giuliana Bacchi; Nadia Wasi; Leslie Schmitz; Paolo R Salvalaggio; Kevin C Abbott; Mark A Schnitzler; Luca Neri; Daniel C Brennan
Journal:  Transplantation       Date:  2008-07-27       Impact factor: 4.939

2.  Risk factors for metabolic syndrome in stable Italian renal transplant patients.

Authors:  Fabio Fabbian; Maurizio Bergami; Christian Molino; Alfredo De Giorgi; Marco Pala; Carlo Longhini; Francesco Portaluppi
Journal:  Clin Exp Nephrol       Date:  2011-03-01       Impact factor: 2.801

Review 3.  Paediatric obesity and renal transplantation: current challenges and solutions.

Authors:  John D Terrace; Gabriel C Oniscu
Journal:  Pediatr Nephrol       Date:  2015-05-28       Impact factor: 3.714

Review 4.  Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review.

Authors:  Ernesto Paoletti; Franco Citterio; Alberto Corsini; Luciano Potena; Paolo Rigotti; Silvio Sandrini; Elisabetta Bussalino; Giovanni Stallone
Journal:  J Nephrol       Date:  2019-04-27       Impact factor: 3.902

Review 5.  Revascularization options in patients with chronic kidney disease.

Authors:  Guha Ashrith; MacArthur A Elayda; James M Wilson
Journal:  Tex Heart Inst J       Date:  2010

Review 6.  Complications associated with new-onset diabetes after kidney transplantation.

Authors:  Adnan Sharif; Keshwar Baboolal
Journal:  Nat Rev Nephrol       Date:  2011-11-15       Impact factor: 28.314

7.  Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.

Authors:  Daniel E Weiner; Meyeon Park; Hocine Tighiouart; Alin A Joseph; Myra A Carpenter; Nitender Goyal; Andrew A House; Chi-Yuan Hsu; Joachim H Ix; Paul F Jacques; Clifton E Kew; S Joseph Kim; John W Kusek; Todd E Pesavento; Marc A Pfeffer; Stephen R Smith; Matthew R Weir; Andrew S Levey; Andrew G Bostom
Journal:  Am J Kidney Dis       Date:  2018-07-20       Impact factor: 8.860

8.  Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure.

Authors:  Krista L Lentine; Lisa A Rocca Rey; Swathy Kolli; Giuliana Bacchi; Mark A Schnitzler; Kevin C Abbott; Huiling Xiao; Daniel C Brennan
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 8.237

9.  Dyslipidemia can be controlled in diabetic as well as nondiabetic recipients after kidney transplant.

Authors:  Vijay Shivaswamy; R Brian Stevens; Ramona Zephier; Myhra Zephier; Junfeng Sun; Gerald Groggel; Judi Erickson; Jennifer Larsen
Journal:  Transplantation       Date:  2008-05-15       Impact factor: 4.939

10.  Metabolic syndrome and coronary artery calcification in renal transplant recipients.

Authors:  Gbemisola A Adeseun; Maria E Rivera; Subhashini Thota; Marshall Joffe; Sylvia E Rosas
Journal:  Transplantation       Date:  2008-09-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.